• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Insufficient evidence for screening for major depressive disorder in children

byNicholas WoolfandSai Folmsbee
February 9, 2016
in Pediatrics, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. From a systematic review, insufficient studies were found examining whether routine screening for pediatric major depressive disorder (MDD) improves depression- or other healthcare-related outcomes.

2. Limited evidence suggests the Patient Health Questionnaire Modified for Adolescents (PHQ-A) and Beck Depression Inventory (BDI) may be the best MDD screening tools for children.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Major depressive disorder (MDD) is prevalent in the pediatric population, with approximately 11% of children aged 8-18 years affected in the last year alone. Moreover, a majority of children suffering from MDD do not receive adequate treatment. A 2009 USPSTF guideline recommended routine screening for MDD in children aged 12 to 18 years in primary care settings, but only if adequate management systems are in place. This review sought to update that guideline by examining available evidence for both screening and treatment of MDD in children. Unfortunately, the review did not find any qualifying trials that directly assessed the benefits and harms of screening children for MDD in primary care settings. Among all MDD screening approaches, the PHQ-A and BDI tools had the highest sensitivity and specificity. In terms of treatment, fluoxetine, fluoxetine with cognitive behavioral therapy (CBT), and collaborative care were associated with the best response rates. This review was limited by strict inclusion criteria (i.e., English language studies related only to MDD screening/treatment in primary care settings), insufficient power to rule out the absence of benefits or harms, and limited generalizability due to heterogeneity in interventions, populations and settings across all included publications. Overall, it is clear that more high-quality studies that examine the utility of pediatric MDD screening in primary care settings are needed.

Click to read the study published today in the Annals of Internal Medicine

Relevant Reading: Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force recommendation statement

In-Depth [systematic review]: This review assessed 5 studies on MDD screening accuracy and 4 trials on treatment efficacy via PubMed, Cochrane Library and PsychInfo searches. There were no meta-analyses or retrospective cohort studies that met inclusion criteria. Across all studies that examined screening accuracy, the PHQ-A and BDI tools had the highest sensitivity (range 73%-90%) and specificity (range 81%-94%). Notably, the positive predictive value was low for these screening tools (range 8%-56%), although the negative predictive value was extremely high (range 97%-99.6%). From the trials that assessed treatment approaches for MDD, it was found that fluoxetine (absolute risk difference 25.7%) and fluoxetine with CBT (absolute risk difference 36.2%; p = 0.001) were associated with a significantly higher response compared to placebo. Additionally, a trial examining collaborative care found that it was associated with significant improvement in response rates at 6 and 12 months compared to the control groups (odds ratios 5.2 and 3.9, respectively).

RELATED REPORTS

Islamic-based interventions may improve both depression and anxiety

Wellness Check: Spirituality

Gratitude-focused writing may improve mental wellness during periods of chronic stress

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depressionscreening
Previous Post

Metabolic syndrome severity decreasing among adolescents

Next Post

Patient demographics associated with fewer hospice visits prior to death

RelatedReports

Children’s hospital visits for suicide ideation and attempts are increasing
Psychiatry

Islamic-based interventions may improve both depression and anxiety

June 22, 2022
Wellness

Wellness Check: Spirituality

June 21, 2022
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Psychiatry

Gratitude-focused writing may improve mental wellness during periods of chronic stress

May 24, 2022
Quick Take: Intimate Partner Homicide of Adolescents
Chronic Disease

Meditation may provide medical benefit for various health outcomes

May 17, 2022
Next Post
Patient demographics associated with fewer hospice visits prior to death

Patient demographics associated with fewer hospice visits prior to death

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Radiofrequency thermal ablation superior to percutaneous ethanol injection in hepatocellular carcinoma [Classics Series]
  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.